|
Market Closed -
Nasdaq
21:00:00 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 25.16 USD | -0.51% |
|
-6.54% | -13.36% |
| 09-21 | Arcutis Biotherapeutics, Inc.(NasdaqGS:ARQT) added to S&P 1000 | CI |
| 09-21 | Arcutis Biotherapeutics, Inc.(NasdaqGS:ARQT) added to S&P 600 Health Care | CI |
| Market Cap | 3.16B 2.81B 2.62B 2.39B 4.51B 304B 4.55B 31.74B 12.3B 155B 11.87B 11.62B 499B | P/E 2026 * |
62.6x | P/E 2027 * | 19.4x |
|---|---|---|---|---|---|
| Enterprise Value | 2.87B 2.55B 2.38B 2.17B 4.1B 276B 4.14B 28.84B 11.18B 141B 10.79B 10.56B 453B | EV / Sales 2026 * |
5.35x | EV / Sales 2027 * | 3.68x |
| Free-Float |
98.23% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ARQT | Delayed | |
CBOE
| ARQT | Real-time |
Last Transcript: Arcutis Biotherapeutics, Inc.
| 1 day | -0.51% | ||
| 1 week | -6.54% | ||
| Current month | -4.81% | ||
| 1 month | +6.34% | ||
| 3 months | -2.52% | ||
| 6 months | +6.47% | ||
| Current year | -13.36% |
| 1 week | 25.01 |  | 27.64 |
| 1 month | 23.1 | | 28.29 |
| Current year | 19.3 | | 30.75 |
| 1 year | 19.3 | | 31.77 |
| 3 years | 1.76 | | 31.77 |
| 5 years | 1.76 | | 31.77 |
| 10 years | 1.76 | | 40.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 58 | 31/03/2017 |
| Corporate Officer/Principal | 71 | 02/12/2025 | |
Latha Vairavan
DFI | Director of Finance/CFO | - | 14/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Patrick Heron
CHM | Chairman | 55 | 30/11/2019 |
Todd Watanabe
BRD | Director/Board Member | 58 | 31/12/2015 |
Howard Welgus
BRD | Director/Board Member | 74 | 31/07/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/09/26 | Sell | General Counsel | -3,674 | 0.0029% | ||
| 15/09/26 | Exercice | Director | 12,922 | 0.0103% | ||
| 08/09/26 | Sell | General Counsel | -9,989 | 0.0079% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.51% | -6.54% | +26.31% | +450.55% | 3.16B | |
| -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | |
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | |
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | |
| Average | -0.74% | -3.71% | +26.09% | +98.07% | 370.04B | |
| Weighted average by Cap. | -0.60% | -3.33% | +29.07% | +71.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 537M 477M 446M 406M 766M 51.66B 773M 5.39B 2.09B 26.41B 2.02B 1.97B 84.75B | 687M 610M 570M 519M 979M 66.04B 988M 6.89B 2.67B 33.76B 2.58B 2.52B 108B |
| Net income | 53.27M 47.33M 44.17M 40.26M 75.94M 5.12B 76.64M 535M 207M 2.62B 200M 196M 8.4B | 173M 154M 144M 131M 247M 16.64B 249M 1.74B 673M 8.51B 650M 636M 27.31B |
| Net Debt | -288M -256M -239M -218M -411M -27.72B -415M -2.89B -1.12B -14.17B -1.08B -1.06B -45.49B | -638M -567M -529M -482M -909M -61.31B -918M -6.4B -2.48B -31.34B -2.39B -2.34B -101B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | US$25.16 | -0.51% | 1,778,472 |
| 01/10/26 | US$25.29 | -4.31% | 1,637,458 |
| 30/09/26 | US$26.43 | -1.20% | 2,391,395 |
| 29/09/26 | US$26.75 | -2.12% | 2,936,918 |
| 28/09/26 | US$27.33 | +1.52% | 3,065,558 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARQT Stock
Select your edition
All financial news and data tailored to specific country editions
